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Cofactors may explain why in some cases food ingestion leads to anaphylaxis while in
others elicits a milder reaction or tolerance. With cofactors, reactions becomemore severe
and/or have a lower allergen threshold. Cofactors are present in up to 58% of food
anaphylaxis (FAn). Exercise, NSAIDs, and alcohol are the most frequently described,
although the underlying mechanisms are poorly known. Several hypotheses have
suggested the influence of these cofactors on basophils and mast cells (MCs). Exercise
has been suggested to enhance MC activation by increasing plasma osmolarity,
redistributing blood flow, and activating adenosine and eicosanoid metabolism.
NSAIDs’ cofactor effect has been related with cyclooxygenase inhibition and therefore,
prostaglandin E2 (PGE2) production. Indeed, overexpression of adenosine receptor 3 (A3)
gene has been described in NSAID-dependent FAn; A3 activation potentiates FcϵRI-
induced MC degranulation. Finally, alcohol has been related with an increase of histamine
levels by inhibition of diamino oxidase (DAO) and also with and increase of extracellular
adenosine by inhibition of its uptake. However, most of these mechanisms have limited
evidence, and further studies are urgently needed. In conclusion, the study of the immune-
related mechanisms involved in food allergic reactions enhanced by cofactors is of the
utmost interest. This knowledge will help to design both tailored treatments and
prophylactic strategies that, nowadays, are non-existent.
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Food allergy is the main cause of anaphylaxis in children and in
some series, also in adults (1). However, only some food allergic
reactions end up being an anaphylaxis, ranging from very low
percentages (0.4%) up to 40% of the reactions in some series (2).
This disparity may be related with differences in age, food trigger,
and geographic area. Interestingly, food allergy in adults usually
debuts in the second-third decade of life and, in up to 50% of the
cases, as an anaphylaxis (1).
The severity of an allergic reaction is unpredictable. The same
individual may present reactions with different severity, even with
the same food. The presence of cofactors, such as NSAIDs, exercise
or alcohol, may explain this heterogeneity. Patients with cofactor-
dependent reactions may have no or mild symptoms with the food
alone and a more severe reaction (generalized urticaria or
anaphylaxis) when associating a cofactor. Indeed, the same
patient may have reactions with different cofactors or even need
more than one cofactor to develop the severe reaction. Cofactors
may increase the severity of the reaction or decreasing the reactivity
threshold, meaning that lower doses of allergen are able to induce a
more severe reaction (from two to six times depending on the
series) (2–6). Cofactors are identified in up to 58% of food
anaphylaxis (FAn) in some series and related with greater severity
(3, 4, 7, 8), but the underlying mechanisms are poorly understood.
Their role in anaphylaxis has been more widely studied in
adult patients, being not yet optimally studied in children. The
high frequency of cofactor-related reactions highlights the
clinical impact of recognizing and including cofactors into
the routine diagnostic workup. Indeed, the understanding of
the underlying mechanisms will help in developing tailored
prophylactic treatments and identifying risk biomarkers.
Hereby we report the main evidence reported regarding the
major cofactors involved in food allergy.EXERCISE
Exercise is described in up to 10% of anaphylactic reactions (3,
4). Exercise-induced anaphylaxis is a syndrome that may occur
in food allergic patients but also independently of food ingestion
(9). Considering the number of published studies, for the
purpose of this review we will focus on food-dependent
exercise-induced anaphylaxis (FDEIA). Several mechanisms
have been postulated, although the evidence supporting each of
them is scarce and limited by the low number of patients
evaluated and the limited quality of the studies, as stated by a
recent position paper from the European Academy of Allergy
and Clinical Immunology (EAACI) (9).
The increase of both gastrointestinal permeability and tissue
transglutaminase activity, two of the proposed mechanisms in
the gut mucosa, is splendidly reviewed elsewhere (9). Other
suggested mechanisms are related with the direct effect of
exercise on basophils and mast cells (MCs) by modifying the
cell count and histamine release (HR), redistributing the blood
flow and increasing plasma osmolarity.Frontiers in Immunology | www.frontiersin.org 2Exercise and Basophil Reactivity
and Count
Acute exercise is related with the transient increase of blood
circulating neutrophils, monocytes, dendritic and NK cells,
although it remains unknown whether these changes may be
also related with an altered immune function (10). Some in vivo
studies have shown an increase of basophils count and HR after
exercise, being more important in atopic individuals (11). In
others, only an increase in HR has been demonstrated with no
modification of basophil count (12). Interestingly, some authors
have not found differences in HR when comparing allergic
patients with controls, regardless of a significant basophil
count increase in the atopic group (11). Indeed, increase in HR
after in vitro IgE activation was only observed in highly trained
athletes compared with non-trained ones, although both groups
were non-atopic (13). Thus, these observations suggest that the
atopic status together with the training level might be
conditioning factors of HR and therefore, of exercise-induced
basophil- and MC-activation. However, the interpretation and
comparison of these findings are often complicated due to
differences in experimental design of the studies (i.e.,
measurement times and methods, samples types and exercise
intensity/duration).
Exercise and Blood Flow Redistribution
It is well known that during exercise, blood flow is redistributed,
being diverted from the viscera to the skeletal muscle, heart, and
skin (14). Mounting evidence supports that HR during exercise is
part of the physiological mechanism of recovery (15). Histamine
acts as a vasodilator and is involved in post-exercise hypotension
and hyperemia (15, 16). Therefore, one hypothesis that may need
further exploration is whether this exercise recovery system in
FDEIA patients is somehow damaged and, therefore, exercise is
inducing “excessive” basophil/MC activation.
Some authors (17) have hypothesized that as a consequence of
the blood flow redistribution, food allergens are transported away
from the gut mucosa where resident MCs tolerate them to other
tissues as skin or skeletal muscles, where MCs with a different
phenotype react. For this reason, FDEIA patients tolerate the food at
rest but have an allergic reaction when doing exercise. This is an
interesting hypothesis and biologically plausible, although there is
no experimental evidence yet.
Exercise and Plasma Osmolarity
Another effect of exercise is plasma osmolarity increase, which
magnitude depends on exercise intensity and the resulting
dehydration (9). Several in vitro studies have demonstrated
that hyperosmolar environments induce MC and basophil
activation. Torres-Atencio et al. (18) showed that mannitol, as
a hyperosmolar stimulus, induced significant activation in MC
from LAD2 cell line and healthy individuals (MC derived from
CD34+ peripheral blood cells and primary lung MC). Other
authors, in three patients (one FDEIA and two food allergic) and
three healthy controls, showed that changes in osmolarity
increase basophil activation only in FDEIA, but not in controls
or food allergic patients (19). However, the in vitro osmolarityFebruary 2021 | Volume 11 | Article 623071
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reached during exercise or dehydration in physiological
conditions (293–305 mOsm) (9, 20).
Exercise and Adenosine Metabolism
Adenosine is produced under conditions of increased energy
consumption such as hypoxia or stress, rapidly increasing its
circulating levels (21). Adenosine induces opposite effects in MC
activation depending on the binding receptor (22). Whereas A2A
ligation results in an increase of cAMP, and therefore, the
inhibition of MC mediator release, A2B enhances MC
activation through PLC. Finally, A3 seems to be involved in the
potentiation of IgE-mediated MC activation in mouse and
human models (22). Like the observations in PGE2–EP axis,
the expression profile of adenosine receptors in the cell’s surface
may condition the final effect of adenosine. Gomez et al. (23)
demonstrated that adenosine enhanced IgE-mediated
degranulation via A3 in human lung derived MC but not in
skin MC. Interestingly, lung MCs were shown to express three-
fold more A3 mRNA than the skin ones.
Adenosine is released into the venous efflux from skeletal
muscle fibers in response to muscle contraction during exercise.
Accumulated evidence shows that it is partially responsible for
muscle hyperemia at submaximal and maximal workloads due to
its effect on A2A that results in vasodilation (24). Indeed, one of
the most important factors regulating exercise capacity is the
vasodilatation of the exercising muscle (25). In vivo studies
performed in chronic heart failure patients have shown that
adenosine release is impaired, partially explaining the reduced
exercise capacity observed in these patients (25). Interestingly,
some studies have shown that trained athletes have higher
adenosine baseline plasma levels when compared with
recreational ones (26). A previous publication of Muñoz-Cano
et al. (27) showed that cofactor-related FAn patients (NSAIDs
and exercise) overexpressed A3 gene (ADORA3) and others
related with adenosine metabolism. Interestingly, although A3
activation has been linked to anti-inflammatory effects in several
models of inflammation (28), it has also been related with the
enhancement of IgE-mediated degranulation in human MC and,
thus contributing to allergic inflammation (29, 30). Therefore, we
hypothesized that the adenosine released during exercise in
FDEIA patients would preferably bind A3 with no deleterious
effect in the absence of allergen. However, in the presence of
allergen, adenosine would have a synergistic effect on MC
activation, favoring the allergic reaction. However, further
studies need to be conducted to confirm this theory.
Exercise and Eicosanoid Metabolism
Finally, another potential underlying mechanism in FDEIA may
be related with the eicosanoid metabolism. Exercise is related
with an increase in serum of products from the eicosanoid
metabolism, as well as, cyclooxygenase (COX)-1 and 2-derived
prostanoids (TXB2, PGE2, PGD2,…) and lipoxygenase (5-LOX,
12-LOX, 15-LOX) as a physiological response (31).
Different models have demonstrated that PGE2 abrogates
IgE-mediated MC activation (32–34). Particularly misoprostol,
a PGE1 analog, has shown to suppress symptoms in wheat-Frontiers in Immunology | www.frontiersin.org 3dependent exercise-induced anaphylaxis and IgE-mediated
histamine release in both allergic rhinitis and healthy
individuals (35–37). Rastogi et al. (38) have shown that
patients with hymenoptera anaphylaxis had lower baseline
PGE2 serum levels, suggesting that PGE2 may protect from
anaphylaxis. Conversely, a very recent publication of Muñoz-
Cano et al. (39) did not find any differences in plasma PGE2 at
baseline in a series of FAn patients. Differences in the sample
type and cause of anaphylaxis may account for this discrepancy.
Although there is no data regarding PGE2 levels at baseline or
otherwise in FDEIA, we could suggest, as a hypothesis, that these
patients may have a deficient production of PGE2 during exercise
that would be predisposing to anaphylaxis in the presence of
the allergen.NSAIDS
Non-steroidal anti-inflammatory drugs (NSAIDs) constitute a
heterogenous group of widely used drugs with analgesic, anti-
pyretic, and anti-inflammatory properties. Their main
mechanism of action, despite the differences in their chemical
structure, depends on prostanoid (prostaglandins and
thromboxane) inhibition by blocking COX activity (40).
However, some NSAIDs have COX-independent effects, such
as the ability to modulate several transcription factors that
control the expression of genes involved in inflammation (f.i.
nuclear factor-kappa B) or signaling pathways (MAPK or PI3k/
Akt) (41).
NSAIDs, as a cofactor, are involved in up to 25% of food-
induced anaphylaxis and are considered a risk factor with an
odds ratio >11 (42). Several studies have shown that NSAIDs can
also induce anaphylaxis in FDEIA patients despite that NSAIDs
were not originally involved in previous reactions (43, 44). The
underlying mechanisms of this synergistic effect are not
completely understood, and two main theories have been
suggested. One is related with the alteration of intestinal
permeability by NSAIDs leading to an increase of allergen
absorption (45) and the other suggesting a direct effect of
NSAIDs on basophils and MC.
NSAIDs and Eicosanoid Metabolism
NSAIDs have shown to induce MC activation in certain human
and animal models. In NSAID exacerbated respiratory disease
(N-ERD) patients, Steinke et al. showed that aspirin induced MC
activation by measuring calcium influx and PGD2 release (46).
Interestingly, it has also been demonstrated that N-ERD patients
have a decreased expression of PGE2 receptor 2 (EP2) that may
contribute to reducing PGE2 capacity to mediate anti-
proliferative and anti-inflammatory effects (47). Indeed, N-
ERD has also decreased production of PGE2 (48).
Matsuo et al. (49) showed that aspirin did not induce HR by
itself but enhanced IgE-mediated basophil activation.
Interestingly, the authors suggested that this effect was not
related with a COX-dependent mechanism but with Syk
phosphorylation. On the contrary, Pascal et al. (50) showed
that the ability of NSAID to enhance the IgE-mediated reactionsFebruary 2021 | Volume 11 | Article 623071
Muñoz-Cano et al. Mechanism in Food Allergyin FAn patients may be COX1-dependent. Using a model of
basophil activation test, these authors demonstrated that the
activation with the allergen (peach lipid transfer protein) was
enhanced by aspirin. However, this effect was not observed when
co-stimulating with valdecoxib (selective COX-2 inhibitor). In
the same line, Wojnar et al. showed that several chemically
unrelated NSAIDs (non-selective COX inhibitors) enhanced HR
induced by ragweed (51). Indeed, Matsukura (43) and Aihara
(52) demonstrated a potentiation of the allergic reaction with
aspirin but not with nimesulide and etodolac, both preferential
COX-2 inhibitors, in FDEIA patients.
Finally, several authors have demonstrated that PGE2 prevents
MC degranulation when acting through EP2 and induces a pro-
inflammatory response when signaling through EP3 (18, 32, 53).
Very recently, Rastogi et al. (38) have shown that anaphylaxis in
mice can be prevented by blocking PGE2 degradation. They also
showed that MC IgE-mediated degranulation is suppressed by
PGE2 through EP4 in mouse MC and through both EP2 and EP4
ligation in human skin MC. It has been suggested that the ratio of
EP receptors expressed on cell’s surface may be determinant in the
final effect of PGE2. EP3 is considered to mediate pro-inflammatory
effects, and EP2 and EP4 have anti-inflammatory activity (32). Also
very recently, Muñoz-Cano et al. (39) showed that PGE2 reduced
IgE-mediated basophil activation in patients with FAn.
Furthermore, these authors showed a decreased expression of EP4
(anti-inflammatory) and increased expression of EP3 (pro-
inflammatory) receptors in basophils. However, they did not find
differences among EP pattern expression when comparing FDNIA
and FAn, and all patients had a ratio EP3/EP4+EP2 favoring a pro-
inflammatory activation upon PGE2 ligation.
All this suggests that eicosanoid metabolism may be involved
in the development of anaphylaxis in general, and therefore,
anything blocking PGE2 production, such as NSAIDs, may
facilitate the development of a severe reaction. However, if that
seems to be a universal mechanism in anaphylaxis, we must
wonder why not all food allergic patients require a cofactor in
order to have an anaphylaxis. In this line, Pascal et al. (50)
showed that the synergistic effect of NSAID was present in both
NSAID-dependent (FDNIA) and -independent FAn patients,
and the main difference between them was the basophil
sensitivity. Thus, FAn (NSAID-independent) patients had
higher (about 148-fold) basophil sensitivity, requiring further
less allergen concentration to elicit 50% of basophil maximal
response compared to FDNIA patients. This suggests that
enough allergen concentration could elicit an anaphylaxis in
the absence of a cofactor in FDNIA. A similar observation was
made in FDEIA patients in vivo, where the increase of the
amount of allergen was enough to reproduce the anaphylaxis
in the absence of exercise (43, 52, 54). Some other evidence of the
differences in the pathogenic mechanism in cofactor-dependent
and -independent anaphylaxis was provided by Muñoz-Cano
et al. (27), who reported differences at transcriptome level. Thus,
altered B-cell pathways, increased markers of neutrophil
activation and reactive oxygen species levels were exclusively
observed in FAn patients. However, adenosine metabolism
related genes were differentially expressed only in FDNIA.Frontiers in Immunology | www.frontiersin.org 4Altogether, these findings suggest that (1) eicosanoid
metabolism may play a role in the development of any
anaphylaxis; (2) NSAID may have a universal synergistic effect
in any food allergic patient; (3) the right amount of allergen may
induce an anaphylaxis in FDNIA even in the absence of a
cofactor; and (4) there are other yet to be confirmed
mechanisms that explain the differences between NSAID-
dependent and -independent FAn.
NSAIDs and Adenosine Metabolism
Adenosine metabolism has been linked to some NSAID-
exacerbated cutaneous and respiratory diseases. ADORA3
polymorphism has been identified in NSAID-exacerbated
urticaria patients (55) and ADORA1 and ADORA2A in N-
ERD patients (56). Cronstein et al. (57–59) showed in a series
of studies with animal and human models that NSAIDs at
pharmacologic concentrations increase the release of adenosine
into the extracellular milieu by uncoupling oxidative
phosphorylation and, therefore, increasing ATP catabolism.
These authors have suggested that the anti-inflammatory
effects of NSAIDs are partly COX-independent and mediated
by adenosine. However, considering that the receptor expression
profile in the cell’s surface may condition the final effect of
adenosine, as in the PGE2–EP axis, the anti-inflammatory effect
of adenosine in these models may be related with a particular
expression pattern of the cells/mouse strains studied.
Muñoz-Cano et al. (27) observed that FDNIA patients had a
unique transcriptome signature related with adenosine
metabolism genes, particularly an overexpression of ADORA3
that may be having a dual effect in these patients. A3 agonists have
also shown anti-inflammatory effects in several mouse models due
to inhibition of IFN-g (60, 61). Interestingly, these authors also
showed that FDNIA patients had a repressed IFN-g production
and IFN-g-regulated genes. Considering that FDNIA patients
usually have no or mild reaction when exposed to the allergen
alone, A3R may be exerting its protective (anti-inflammatory)
effect in this scenario through IFN-g repression. However, when
the patient is exposed to the food allergen plus NSAID, the
adenosine released by NSAIDs, via A3, would enhance the IgE-
mediated reaction, resulting in a systemic reaction. Nevertheless,
further studies are still needed to completely understand the
specific role of adenosine metabolism in FAn.
Finally, Pouliot et al. (62) showed that adenosine up-regulates
COX-2 expression, with a consequent increase of PGE2
production through A2A. These findings suggest that the
inhibitory effect of A2A receptor depends on COX2-PGE2–EP
axis. The potential connection between adenosine and PGE2
metabolism, both apparently involved in the development of
FDNIA, opens an exciting research field that must still
be developed.ALCOHOL
Alcohol is one of the classic cofactors in FAn, present in up to
15% of cases in some series (2), although the evidence supportingFebruary 2021 | Volume 11 | Article 623071
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some hypothesis based on evidence of alcohol effect on immune
cells that we briefly review hereby.
Some authors have shown that alcohol modifies intestinal
permeability due to local activation of MC and modification of
the expression of tight junction-associated proteins by
acetaldehyde, one of its metabolites (63, 64). Actually,
acetaldehyde-induced MC activation is one of the suggested
mechanisms involved in alcohol-induced asthma in Japanese
patients. It is well known that this population has a defective
alcohol catabolism (aldehyde dehydrogenase 2 decreased
activity) that facilitates acetaldehyde accumulation (64).
Alcohol has also been shown to increase histamine levels by
inhibiting diamino oxidase (DAO), an enzyme that catabolizes
histamine (65). It has also been described that alcohol induces
pro-inflammatory mediator (such IL-6, IL-10, and IFN-g) release
and eicosanoid metabolite production, such as PGE2 (66).
Similar to the hypothesis in FDEIA, food-dependent alcohol-
induced anaphylaxis (FDAIA) patients could have a deficient
production of PGE2. Further studies evaluating the productions
of eicosanoid metabolites in these patients would shed light upon
the underlying mechanism.
Finally, adenosine metabolism again, may be involved in
FDAIA. Alcohol inhibits adenosine uptake, increasing its
extracellular levels (67). However, this effect is only observed
in acute consumption, and chronic intake does not modifyFrontiers in Immunology | www.frontiersin.org 5adenosine transport (67). So, as suggested in FDNIA,
adenosine released upon alcohol consumption may enhance
the IgE-mediated reaction induced by food allergen.
Conversely to the observation in FDNIA patients, no data
regarding expression profile of adenosine receptors in
FDAIA exists.DISCUSSION
The limited knowledge about the mechanisms involved in
cofactor-enhanced FAn (CEFA) makes exceedingly difficult the
development of prophylactic strategies. Apparently, avoiding
strategies in CEFA patients may seem straightforward.
However, in those allergic to ubiquitous allergens (f.i. nuts) or
panallergens such as lipid transfer proteins, avoiding strategies
are quite complicated considering that cofactors are everyday
common situations (f.i. physical activity).
Although the evidence in CEFA is limited, and we are currently
working mostly based on hypothesis, the high complexity of the
underlying mechanism seems evident. In the light of this data and
other existent evidence not reviewed in this manuscript, several
pathogenic mechanisms may be intertwined. The “cofactor effect”
seems to be a universal phenomenon as demonstrated in in vivo
and in vitro experiments not only in FAn patients but also in
healthy individuals (43, 49, 50, 54). That means that (1) a personalFIGURE 1 | Mechanisms in cofactor-enhanced food anaphylaxis. Adenosine and eicosanoid metabolism hypothesis. The panel depicts the most frequent cofactors
involved in food anaphylaxis (from top to bottom): alcohol, exercise, and non-steroidal anti-inflammatory drugs (NSAIDs). Mild reactions in the absence of a cofactor
may end up in an anaphylaxis with the same amount of allergen together with the presence of a cofactor. Ado, adenosine; green arrows, increase; red arrows,
decrease. *Evidence based on references (23, 26, 28, 29, 38, 39, 41, 50, 57–59, 66, 67).February 2021 | Volume 11 | Article 623071
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anaphylaxis), and (2) most cofactors are interchangeable and
capable of reproduce an anaphylaxis. Considering the unrelated
nature of the cofactors, this observation may suggest that all of
them may share, somehow, some common pathogenic
mechanisms. One may suspect that all these cofactors are
interfering with a compensatory system that is blocking (totally
or partially) the allergic reaction induced by the food alone. The
adenosine and eicosanoid metabolisms (Figure 1) and/or the
disruption of intestinal permeability (not reviewed here) may be
some of these mechanisms. In conclusion, and at risk of sounding
cliché, further studies are needed to understand this “cofactor
effect” and to identify risk biomarkers and prophylactic treatments.Frontiers in Immunology | www.frontiersin.org 6AUTHOR CONTRIBUTIONS
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